Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Other Non-Current Assets (2018 - 2023)

Avai Bio's Other Non-Current Assets history spans 6 years, with the latest figure at $125.0 for Q1 2023.

  • On a quarterly basis, Other Non-Current Assets rose 100.1% to $125.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $125.0, a 100.1% increase, with the full-year FY2023 number at $125.0, up 100.1% from a year prior.
  • Other Non-Current Assets hit $125.0 in Q1 2023 for Avai Bio, up from -$131394.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for AVAI hit a ceiling of $8111.0 in Q2 2020 and a floor of -$131394.0 in Q1 2022.
  • Historically, Other Non-Current Assets has averaged -$12801.2 across 5 years, with a median of $1938.0 in 2020.
  • Biggest five-year swings in Other Non-Current Assets: surged 14647.27% in 2020 and later crashed 6879.88% in 2022.
  • Tracing AVAI's Other Non-Current Assets over 5 years: stood at $55.0 in 2019, then skyrocketed by 3547.27% to $2006.0 in 2020, then dropped by 3.39% to $1938.0 in 2021, then crashed by 6879.88% to -$131394.0 in 2022, then skyrocketed by 100.1% to $125.0 in 2023.
  • Business Quant data shows Other Non-Current Assets for AVAI at $125.0 in Q1 2023, -$131394.0 in Q1 2022, and $1938.0 in Q1 2021.